Cargando…

Plasma uric acid and renal haemodynamics in type 2 diabetes patients

AIM: Increased plasma uric acid (PUA) concentrations are associated with chronic kidney disease in type 2 diabetes (T2D) patients. The mechanisms involved remain unclear. We investigated the relation between PUA and (intra)renal haemodynamics in T2D patients without overt kidney disease. METHODS: Ei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Suijk, Danii LS, Smits, Mark M, Muskiet, Marcel HA, Tonneijck, Lennart, Kramer, Mark HH, Joles, Jaap A, van Raalte, Daniël H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons Australia, Ltd 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065078/ https://www.ncbi.nlm.nih.gov/pubmed/31429150 http://dx.doi.org/10.1111/nep.13645

Ejemplares similares

Renal sinus fat and renal hemodynamics: a cross-sectional analysis
por: Spit, Karlinde A., et al.
Publicado: (2019)

Postprandial renal haemodynamic effects of the dipeptidyl peptidase‐4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double‐blind trial
por: Muskiet, Marcel H. A., et al.
Publicado: (2021)

Erratum. Renal Effects of DPP-4 Inhibitor Sitagliptin or GLP-1 Receptor Agonist Liraglutide in Overweight Patients With Type 2 Diabetes: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Trial. Diabetes Care 2016;39:2042–2050
por: Tonneijck, Lennart, et al.
Publicado: (2019)

Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial
por: Tonneijck, Lennart, et al.
Publicado: (2016)

Effects of dipeptidyl peptidase‐4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8‐week, randomized, controlled, double‐blind trial
por: Kraaijenhof, Jordan, et al.
Publicado: (2020)

Biliary effects of liraglutide and sitagliptin, a 12‐week randomized placebo‐controlled trial in type 2 diabetes patients
por: Smits, Mark M., et al.
Publicado: (2016)

Cardiovascular, renal and gastrointestinal effects of incretin-based therapies: an acute and 12-week randomised, double-blind, placebo-controlled, mechanistic intervention trial in type 2 diabetes
por: Smits, Mark M, et al.
Publicado: (2015)

Acute plasma amylase increase after glucagon‐like peptide ‐1 receptor agonist exenatide administration in Type 2 diabetes
por: Smits, M. M., et al.
Publicado: (2017)

Skin microvascular function and renal hemodynamics in overweight patients with type 2 diabetes: A cross‐sectional study
por: Bouman, Emma J., et al.
Publicado: (2021)

The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes
por: Sivalingam, Suvanjaa, et al.
Publicado: (2021)

Renal haemodynamic and protective effects of renoactive drugs in type 2 diabetes: Interaction with SGLT2 inhibitors
por: Scholtes, Rosalie A., et al.
Publicado: (2021)

Twelve week liraglutide or sitagliptin does not affect hepatic fat in type 2 diabetes: a randomised placebo-controlled trial
por: Smits, Mark M., et al.
Publicado: (2016)

Uric acid in advanced heart failure: relation to central haemodynamics and outcome
por: Deis, Tania, et al.
Publicado: (2022)

Glucosuria Interferes With Measurement of Effective Renal Plasma Flow Using para-Aminohippuric Acid, With a Focus on SGLT2 Inhibitors
por: Scholtes, Rosalie A., et al.
Publicado: (2020)

Association of Renal Manifestations with Serum Uric Acid in Korean Adults with Normal Uric Acid Levels
por: Jung, Dong-Hyuk, et al.
Publicado: (2010)

Renal effects of uric acid: hyperuricemia and hypouricemia
por: Park, Jung Hwan, et al.
Publicado: (2020)

High plasma uric acid concentration: causes and consequences
por: de Oliveira, Erick Prado, et al.
Publicado: (2012)

Albumin is an interface between blood plasma and cell membrane, and not just a sponge
por: van de Wouw, Jens, et al.
Publicado: (2021)

The influence of serum uric acid on renal function in patients with calcium or uric acid stone: A population-based analysis
por: Tanaka, Yoshimi, et al.
Publicado: (2017)

Study on the mechanism of Phellinus igniarius total flavonoids in reducing uric acid and protecting uric acid renal injury in vitro
por: Chen, Dongming, et al.
Publicado: (2023)

Haemodynamic, endocrine and renal actions of adrenomedullin 5 in an ovine model of heart failure
por: Rademaker, Miriam T., et al.
Publicado: (2012)

Uric Acid
Publicado: (1900)

Uric Acid
Publicado: (1898)

SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria
por: Chino, Yukihiro, et al.
Publicado: (2014)

On Hæmodynamics
por: Griffiths, W. Handsel
Publicado: (1868)

Symposium on Hæmodynamics in Pregnancy. v. Hæmodynamics in Pregnancy
por: Kellar, Robert J.
Publicado: (1950)

Corrigendum: Safety of Semaglutide
por: Smits, Mark M., et al.
Publicado: (2021)

Safety of Semaglutide
por: Smits, Mark M., et al.
Publicado: (2021)

The Adaptive Renal Response for Volume Homeostasis During 2 Weeks of Dapagliflozin Treatment in People With Type 2 Diabetes and Preserved Renal Function on a Sodium-Controlled Diet
por: Scholtes, Rosalie A., et al.
Publicado: (2022)

Haemodynamic effects of plasma-expansion with hyperoncotic albumin in cirrhotic patients with renal failure: a prospective interventional study
por: Umgelter, Andreas, et al.
Publicado: (2008)

A proposal for identifying the low renal uric acid clearance phenotype
por: Indraratna, Praveen L, et al.
Publicado: (2010)

Uric acid in the pathogenesis of metabolic, renal, and cardiovascular diseases: A review
por: Sharaf El Din, Usama A.A., et al.
Publicado: (2017)

Uric Acid and Impairment of Renal Function in Non-diabetic Hypertensive Patients
por: Hung, Yi-Hsin, et al.
Publicado: (2022)

Uric Acid and Oxidative Stress—Relationship with Cardiovascular, Metabolic, and Renal Impairment
por: Gherghina, Mihai-Emil, et al.
Publicado: (2022)

Renal haemodynamic response to sodium‐glucose cotransporter‐2 inhibition does not depend on protein intake: An analysis of three randomized controlled trials
por: van der Aart‐van der Beek, Annemarie B., et al.
Publicado: (2021)

Uric Acid and the Heart
Publicado: (2005)

Dissertation on the Uric Acid
Publicado: (1808)

Injection of Uric Acid
Publicado: (1873)

Uric Acid Toxaemia
por: Dixon, Arch
Publicado: (1900)

Association between serum uric acid and renal outcome in patients with biopsy-confirmed diabetic nephropathy
por: Zou, Yutong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pbf9ir3ojmn9cnhdqu3jd96fbv